A new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most effective. The method also works for other forms of cancer where resistance may develop. A step is now being taken towards better and more personalized treatment for the disease.
Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer
